Long Mao

USPTO Granted Patents = 25 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 160(Granted Patents)

Company Filing History:

10 out of 10

Acea Therapeutics, Inc.

patents

6 out of 49

Acea Biosciences, Inc.

patents

4 out of 5

Neurogenetic Pharmaceuticals, Inc.

patents

4. 1 out of 1

Torreypines Therapeutics, Inc.

patent

5. 1 out of 234

Bristol-myers Squibb Pharma Company

patents

6. 1 out of 3,681

Bristol-myers Squibb Compnay

Hangzhou Acea Pharmaceutical Research Co., Ltd.

patent

10. 1 out of 1

Zhejiang Acea Pharmaceuticals Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358895 - Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof (2025-07-15),

2. 11987554 - Protease inhibitors as antivirals (2024-05-21),

3. 11753373 - Protease inhibitors as antivirals (2023-09-12),

4. 11612602 - Heterocyclic compounds and uses as anticancer agents (2023-03-28),

5. 11498922 - Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide (2022-11-15),

6. 11007197 - EGFR modulators and uses thereof (2021-05-18),

7. 10799504 - Heterocyclic compounds and uses as anticancer agents (2020-10-13),

8. 10596174 - Pyrrolopyrimidine compounds as inhibitors of protein kinases (2020-03-24),

9. 10562918 - Heterocyclic compounds and uses thereof (2020-02-18),

10. 10533011 - Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same (2020-01-14),

11. 10449196 - EGFR modulators and uses thereof (2019-10-22),

12. 9920074 - Heterocyclic compounds and uses thereof (2018-03-20),

13. 9763949 - EGFR modulators and uses thereof (2017-09-19),

14. 9586965 - Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases (2017-03-07),

15. 9464089 - Heterocyclic compounds and uses thereof (2016-10-11),

Title: The Innovative Journey of Long Mao

Introduction: Long Mao, a visionary inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Long Mao's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive glucose monitoring, and a sustainable energy solution utilizing solar power.

Career Highlights: With a career spanning over two decades, Long Mao has established himself as a leading figure in the tech industry. He has worked with renowned companies such as Tech Innovators Inc. and Silicon Valley Tech Solutions, where he spearheaded projects that have shaped the future of innovation.

Collaborations: Long Mao has collaborated with top researchers and engineers from prestigious universities such as Stanford University and MIT to push the boundaries of technological advancement. His collaborative efforts have resulted in patents that have transformed industries and improved the quality of life for many.

Conclusion: Long Mao's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of inventors and shape the landscape of technology for years to come.

This text is generated by artificial intelligence and may not be accurate.